SCIENTIFIC HUB

Follow the evidence.

SCIENTIFIC LITERATURE · PPR

Integrative Transcriptomic and Machine Learning Analysis Reveals a Robust Gene Signature in Parkinson’s Disease

· 2026-02-06

DOI: 10.21203/rs.3.rs-8799127/v1

Check source for accessPreprintOriginal source ↗

Research overview

The text below is the source article’s original abstract under a verified reuse license. cc by

Abstract Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by dopaminergic neuron loss in the substantia nigra and the accumulation of misfolded α-synuclein, leading to motor and non-motor symptoms. Early and accurate diagnosis remains challenging due to the gradual onset of symptoms and disease heterogeneity. In this study, we combined brain-region–specific transcriptomic profiling with interpretable machine learning to identify robust and biologically meaningful predictive gene signatures for PD. Differential gene expression analysis of post-mortem PD and control brain samples revealed a set of significantly dysregulated genes, predominantly involved in mitochondrial function, synaptic signaling, and calcium-mediated neuronal processes. Using Random Forest, Logistic Regression, and XGBoost classifiers, we derived a core set of seven overlapping genes (CALM1, DCLK1, FGF13, HMGN2, PRKACB, SV2C, TAC1) that consistently contributed to PD classification across models. Feature importance and model interpretability analyses highlighted these genes as key drivers of predictive performance. The final gene set achieved robust classification with cross-validated ROC-AUC of 0.845 and was further validated using an independent external dataset (ROC-AUC = 0.743), demonstrating generalizability across cohorts. Functional enrichment analysis linked these genes to neuronal signaling, synaptic function, and Parkinson’s disease–relevant pathways, providing mechanistic context to their predictive power. Overall, our integrative approach illustrates the potential of combining transcriptomics with explainable machine learning to generate reliable, interpretable molecular biomarkers for PD, which may facilitate early diagnosis and improve understanding of disease biology.

Scientific assessment

01

Research question

Assess the question within the original study’s scope.

02

Methods & sample

Check the source article for study design and sample details.

03

Key findings

An editorially approved findings summary is not yet published for this record.

04

Limitations

Generalizability, bias and clinical meaning require separate assessment.

Methods, samples and clinical conclusions are not inferred from bibliographic metadata.